Stay updated on Losmapimod in COVID: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.

Latest updates to the Losmapimod in COVID: Safety & Efficacy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter revision metadata updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision labels updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision: v3.4.3 implemented; no visible changes to study content or user-facing functionality.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now shows Revision: v3.4.2 added and the prior Revision: v3.4.1 removed, along with the old government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedNotice added about a lapse in government funding and NIH operating status. Site version updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check88 days agoChange DetectedUI text updates include glossary toggle options, capitalization/phrasing of QC-related labels, and a revision/version indicator. These changes affect display text only and do not modify study content, eligibility criteria, outcomes, or results.SummaryDifference0.3%

Stay in the know with updates to Losmapimod in COVID: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.